It is shown that CRC cells transiently adopt a wound-healing program normally used by epidermal keratinocytes during tissue repair to enable metastatic dissemination, and this state is reversible, as cells reacquire primary tumor–like characteristics upon colonization of distant organs.
Abstract
Metastasis is the principal cause of death from colorectal cancer (CRC), yet the cellular states that enable tumor dissemination remain poorly defined. Disseminated tumor cells (DTCs) are rare, transient, and clinically inaccessible, limiting mechanistic insight into their biology. Here we show that CRC cells transiently adopt a wound-healing program normally used by epidermal keratinocytes during tissue repair to enable metastatic dissemination. Using serial orthotopic transplantation of patient-derived organoids to model metastasis, we find that DTCs lose cancer stem cell features and instead express wound-inducible keratins, including KRT17, before metastatic outgrowth. This state is reversible, as cells reacquire primary tumor–like characteristics upon colonization of distant organs. Mechanistically, this transition is associated with reduced EZH2 activity and activation of YAP signaling. Clinically, KRT17⁺ cells localize to the invasive front of primary CRCs and are absent from adjacent normal tissue. These findings uncover unexpected lineage plasticity across distinct developmental origins and identify a transient, targetable state critical for metastatic progression. The plasticity of disseminated tumor cells (DTCs) remains to be understood. Here the authors use serial orthotopic transplantation of colorectal patient-derived organoids to mimic cancer metastasis, and observe that DTCs have transiently adopted a wound-healing program of epidermal keratinocytes to express keratins before the metastatic outgrowth in distant organs.
A transitional stage between tumor cell dissemination and overt metastatic outgrowth characterized by malignant epithelial diversification and inflammatory neutrophil remodeling is defined, providing a framework for investigating biomarkers and therapeutic vulnerabilities during this poorly accessible phase of metastat...
R. Pathania, Brian N. Papas, J. Kosak et al.· bioRxiv· 0 citations
The clinical evidence that suggests a role for KRAS in the formation of colorectal metastases is evaluated and the potential influence of mutant KRAS on each of these phases is discussed.
It is suggested that tissue-adapted NETs serve as crucial microenvironmental cues that support the exit from quiescence and drive metastatic outgrowth, highlighting a promising perioperative therapeutic target for TNBC.
Taiko Kawakami, Yusuke Nakanishi, A. Suzuki et al.· Frontiers in Immunology· 0 citations
These findings uncover CAF–bone-marrow cross-talk as a therapeutic target linking stromal inflammation, immune remodeling, and metastatic progression as a therapeutic target linking stromal inflammation, immune remodeling, and metastatic progression.
Yasuto Takeuchi, Hua-Zi Zhang, T. Murayama et al.· bioRxiv· 0 citations
A framework in which metastasis is dynamically codetermined by tumor cell plasticity and host systemic state is described, contextualized by recent mechanistic insights into how lifestyle and physiological states rewire organ microenvironments to become either permissive or restrictive to metastatic colonization is des...
Gwennan Ward, Álvaro Ruiz-Tabas, P. Altea-Manzano· FEBS Letters· 0 citations
A residual population of quiescent Phgdhhigh DTCs that survived initial innate immune clearance and became transiently enriched in micrometastases are identified, providing insights into the development of micrometastasis-targeting regimens.
Yun-Fan Sun, Y. Zhong, Shang Liu et al.· Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.